Sign in
4

Changes in Ownership

Tarsus Pharmaceuticals, Inc. Filed Acc 0001209191-23-017999

Options or other derivatives

  • Chief Commercial Officer acquired 80,708 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Mottiwala Aziz · Chief Commercial Officer

Table II: Derivative

2 lines
Date Transaction Shares Owned after D/I
2023-03-08 Grant or award : show line 1 in the form Stock Option (right to buy) +48,116 48,116 D
2023-03-08 Grant or award : show line 2 in the form Restricted Stock Units +32,592 32,592 D
Loading xslF345X03/doc4.xml…